Reckitt Benckiser Group

RECKITT’S EXECUTION HOLDS THE KEY (ADD, 10% UPSIDE)

12/02/20 -"Reckitt Benckiser (Add, UK) needs a serious health check-up. We last teased on this UK-based health & hygiene leader in April 2019, when management’s focus on health (the largest business segment) ..."

PDF page sample
Pages
53
Language
English
Published on
12/02/20
Download
You may also be interested by these reports :
03/08/26
Beiersdorf unexpectedly released its H1 figures alongside a downgrade to FY26 guidance. Q2 organic sales declined by 2.3%, while H1 profitability ...
31/07/26
L’Oréal delivered a solid H1 26. Q2 sales beat consensus, driven by Professional Products and Dermatological Beauty, while L’Oréal Luxe grew 4.7% ...
30/07/26
Haleon’s H1 profitability surpassed expectations, with Q2 top-line growth accelerating. The 2026 guidance remains unchanged. Despite this, investors ...
30/07/26
Bic reported Q2 sales, EBIT and EPS comfortably ahead of market expectations, prompting management to upgrade FY26 guidance. While the reported ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO